Skip to main content

Table 1 Clinical characteristics and outcome of sepsis patients stratified according to survival status 30 days after admission

From: Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients

 

All patients

Survivors

Non-survivors

P

n = 1103

n = 786

n = 305

Demographics

    

 Age, years, mean (SD)

61.2 (14.7)

59.7 (14.7)

64.9 (13.9)

<0.0001

 Gender, male, n (%)

671 (60.8)

481 (61.2)

183 (60)

0.73

 Race, white, n (%)

972 (88.8)

689 (87.7)

273 (89.5)

0.45

 Body mass index, kg/m2, mean (SD)

26 (6.2)

26.2 (6.3)

25.5 (5.8)

0.09

 Admission type, medical, n (%)

817 (74.1)

562 (71.5)

247 (81)

0.001

 Charlson score, median (IQR)

4 (3–6)

4 (2–6)

5 (3–6)

0.0001

Site of infection

    

 Pulmonary, n (%)

478 (43.3)

337 (37.1)

135 (44.3)

0.69

 Abdominal, n (%)

215 (19.5)

150 (19.1)

61 (20)

0.74

 Urinary, n (%)

109 (9.9)

84 (10.7)

24 (7.9)

0.69

 Other, n (%)a

173 (15.7)

123 (15.6)

49 (16.1)

0.93

 Coinfection, n (%)

128 (11.6)

92 (11.7)

36 (11.8)

1

Severity of disease in first 24 hours

    

 APACHE IV score, median (IQR)

80 (63–101)

74 (59–92)

98 (81–122)

<0.0001

 SOFA score, median (IQR)b

7 (5–9)

7 (4–9)

9 (6–12)

<0.0001

 Shock, n (%)

373 (33.8)

234 (29.8)

135 (44.3)

<0.001

 Mechanical ventilation, n (%)

851 (77.2)

590 (75.1)

249 (81.6)

<0.05

 Renal replacement therapy, n (%)

115 (10.4)

60 (7.6)

53 (17.4)

<0.001

Outcome

    

 ICU length of stay, days, median (IQR)

4 (2–10)

5 (2–10)

3 (2–8)

<0.01

 ICU mortality, n (%)

227 (20.6)

13 (1.7)

214 (70.2)

<0.001

  1. 12 patients were lost to follow up.aSite of infection: “other” includes cardiovascular infection, mediastinitis and skin infection. bCentral nervous system not included in score. APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment